Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population

Background. Bioavailable 25-hydroxy vitamin D (25(OH)D) has been suggested for the accurate determination of vitamin D status. The purpose of this study was to determine the utility of bioavailable 25(OH)D in assessing vitamin D status when vitamin D-binding protein (VDBP) was significantly altered...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyun-Young Kim, Jin Hyun Kim, Myeong Hee Jung, In Ae Cho, Youngjin Kim, Min-Chul Cho
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/9120467
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549161893888000
author Hyun-Young Kim
Jin Hyun Kim
Myeong Hee Jung
In Ae Cho
Youngjin Kim
Min-Chul Cho
author_facet Hyun-Young Kim
Jin Hyun Kim
Myeong Hee Jung
In Ae Cho
Youngjin Kim
Min-Chul Cho
author_sort Hyun-Young Kim
collection DOAJ
description Background. Bioavailable 25-hydroxy vitamin D (25(OH)D) has been suggested for the accurate determination of vitamin D status. The purpose of this study was to determine the utility of bioavailable 25(OH)D in assessing vitamin D status when vitamin D-binding protein (VDBP) was significantly altered by pregnancy and liver cirrhosis (LC). The role of genotyping of GC, a gene encoding VDBP, in the determination of bioavailable 25(OH)D concentration in a Korean population was also evaluated. Methods. This prospective study enrolled a total of 136 subjects (53 healthy controls, 45 patients with LC, and 38 pregnant women) from 2017 to 2018. The concentrations of total 25(OH)D and VDBP were measured, and bioavailable 25(OH)D concentrations were calculated. GC genotyping was performed to determine rs4588 and rs7041 polymorphisms. Clinical and laboratory data were compared among the three groups of subjects. Results. Median VDBP and total 25(OH)D concentrations were 165.2 μg/ml and 18.5 ng/ml in healthy controls, 76.9 μg/ml and 10.5 ng/ml in patients with LC, and 368.9 μg/ml and 17.7 ng/ml in pregnant women, respectively. Compared with controls, patients diagnosed with LC had significantly lower VDBP and total 25(OH)D concentrations (all P<0.001) while pregnant women had significantly higher VDBP concentrations (P<0.001). Although total 25(OH)D concentrations in pregnant women were similar to those in controls (P=0.394), their bioavailable 25(OH)D concentrations were significantly lower (1.2 vs. 3.0 ng/ml; P<0.001). Among all the three groups combined, the genotype-specific bioavailable 25(OH)D and the genotype-independent bioavailable 25(OH)D concentrations did not differ significantly (P=0.299). Conclusions. Our study has demonstrated that bioavailable 25(OH)D concentration reflects vitamin D status more accurately than the total 25(OH)D concentration, especially in pregnant women. In addition, GC genotyping did not significantly affect bioavailable 25(OH)D concentration. Therefore, if VDBP concentration is significantly altered, the measurement of bioavailable 25(OH)D concentration might facilitate the accurate determination of vitamin D status. However, GC genotyping might be unnecessary.
format Article
id doaj-art-5a1c9da32c74476b804ee482e43efe0d
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-5a1c9da32c74476b804ee482e43efe0d2025-02-03T06:12:04ZengWileyInternational Journal of Endocrinology1687-83371687-83452019-01-01201910.1155/2019/91204679120467Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean PopulationHyun-Young Kim0Jin Hyun Kim1Myeong Hee Jung2In Ae Cho3Youngjin Kim4Min-Chul Cho5Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Republic of KoreaBiomedical Research Institute, Gyeongsang National University Hospital, Jinju 52727, Republic of KoreaBiomedical Research Institute, Gyeongsang National University Hospital, Jinju 52727, Republic of KoreaDepartment of Obstetrics and Gynecology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Republic of KoreaDepartment of Laboratory Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul 02447, Republic of KoreaDepartment of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Republic of KoreaBackground. Bioavailable 25-hydroxy vitamin D (25(OH)D) has been suggested for the accurate determination of vitamin D status. The purpose of this study was to determine the utility of bioavailable 25(OH)D in assessing vitamin D status when vitamin D-binding protein (VDBP) was significantly altered by pregnancy and liver cirrhosis (LC). The role of genotyping of GC, a gene encoding VDBP, in the determination of bioavailable 25(OH)D concentration in a Korean population was also evaluated. Methods. This prospective study enrolled a total of 136 subjects (53 healthy controls, 45 patients with LC, and 38 pregnant women) from 2017 to 2018. The concentrations of total 25(OH)D and VDBP were measured, and bioavailable 25(OH)D concentrations were calculated. GC genotyping was performed to determine rs4588 and rs7041 polymorphisms. Clinical and laboratory data were compared among the three groups of subjects. Results. Median VDBP and total 25(OH)D concentrations were 165.2 μg/ml and 18.5 ng/ml in healthy controls, 76.9 μg/ml and 10.5 ng/ml in patients with LC, and 368.9 μg/ml and 17.7 ng/ml in pregnant women, respectively. Compared with controls, patients diagnosed with LC had significantly lower VDBP and total 25(OH)D concentrations (all P<0.001) while pregnant women had significantly higher VDBP concentrations (P<0.001). Although total 25(OH)D concentrations in pregnant women were similar to those in controls (P=0.394), their bioavailable 25(OH)D concentrations were significantly lower (1.2 vs. 3.0 ng/ml; P<0.001). Among all the three groups combined, the genotype-specific bioavailable 25(OH)D and the genotype-independent bioavailable 25(OH)D concentrations did not differ significantly (P=0.299). Conclusions. Our study has demonstrated that bioavailable 25(OH)D concentration reflects vitamin D status more accurately than the total 25(OH)D concentration, especially in pregnant women. In addition, GC genotyping did not significantly affect bioavailable 25(OH)D concentration. Therefore, if VDBP concentration is significantly altered, the measurement of bioavailable 25(OH)D concentration might facilitate the accurate determination of vitamin D status. However, GC genotyping might be unnecessary.http://dx.doi.org/10.1155/2019/9120467
spellingShingle Hyun-Young Kim
Jin Hyun Kim
Myeong Hee Jung
In Ae Cho
Youngjin Kim
Min-Chul Cho
Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
International Journal of Endocrinology
title Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
title_full Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
title_fullStr Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
title_full_unstemmed Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
title_short Clinical Usefulness of Bioavailable Vitamin D and Impact of GC Genotyping on the Determination of Bioavailable Vitamin D in a Korean Population
title_sort clinical usefulness of bioavailable vitamin d and impact of gc genotyping on the determination of bioavailable vitamin d in a korean population
url http://dx.doi.org/10.1155/2019/9120467
work_keys_str_mv AT hyunyoungkim clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation
AT jinhyunkim clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation
AT myeongheejung clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation
AT inaecho clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation
AT youngjinkim clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation
AT minchulcho clinicalusefulnessofbioavailablevitamindandimpactofgcgenotypingonthedeterminationofbioavailablevitamindinakoreanpopulation